Highly Multiplexed Single-Cell Proteomics Identifies Key Inflammatory Mediators in Severe COVID-19
Join Today's Clinical Lab and Victor Tek to learn more about how IsoPlexis technology can accelerate your research projects
Today's Clinical Lab
Today’s Clinical Lab is a reader-centric publication that keeps clinical professionals up to date with today’s rapidly changing lab industry with in-depth and timely editorial content and resources, including clinical industry news and insights into the latest trends, technologies, and techniques in the clinical lab.
Highly Multiplexed Single-Cell Proteomics Identifies Key Inflammatory Mediators in Severe COVID-19
In this webinar, IsoPlexis product manager Victor Tek discusses how researchers used IsoPlexis’ low volume highly multiplexed bulk proteomics (CodePlex) to investigate the role of airway and plasma immune cells in the pathogenesis of severe COVID-19. Learn more about how IsoPlexis technology can accelerate your current or future research projects.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.
